C12Y 105/01001
Pyrroline-2-carboxylate reductase
Official title: Pyrroline-2-carboxylate reductase (1.5.1.1)
C12Y105/01001 (Pyrroline-2-carboxylate reductase) appears on 3 US grants and 5 published applications in this corpus.
Search patents in C12Y- Granted patents
- 3
- Published applications
- 5
- Assignees
- 3
- Inventors
- 5
- Latest grant
- 17 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2021 | 0 | 1 |
| 2022 | 0 | 1 |
| 2023 | 0 | 0 |
| 2024 | 1 | 2 |
| 2025 | 1 | 1 |
| 2026 | 1 | 0 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Compositions comprising Propionibacterium acnes bacteriophages for treating acne17 Mar 2026US 12,576,024 B2Phi Therapeutics, Inc.
- Production method for L-cyclic amino acids8 Apr 2025US 12,270,060 B2Ube Corporation
- Compositions comprising Propionibacterium acnes bacteriophages for treating acne20 Feb 2024US 11,903,984 B1Phi Therapeutics, Inc.
- Production method for l-cyclic amino acids31 Jul 2025US 2025/0243520 A1Ube Corporation
- Compositions comprising propionibacterium acnes bacteriophages for treating acne13 Jun 2024US 2024/0189220 A1Phi Therapeutics, Inc.
- Compositions comprising propionibacterium acnes bacteriophages for treating acne29 Feb 2024US 2024/0066079 A1Phi Therapeutics, Inc.
- Production method for l-cyclic amino acids1 Sep 2022US 2022/0275410 A1Api Corporation
- Compositions comprising propionibacterium acnes bacteriophages for treating acne4 Nov 2021US 2021/0338569 A1Phi Therapeutics, Inc.
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.